Hair Growth in a Patient with Alopecia Areata on Tocilizumab
January 2021
in “
Skin appendage disorders
”
New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide → 
Studysummary This case report describes a 21-year-old woman with progressive alopecia areata who experienced hair regrowth while treated with tocilizumab for posterior uveitis, suggesting the potential for this drug to affect hair loss and regrowth by disrupting interleukin-6 signaling.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document described a 21-year-old woman with alopecia areata (AA) who showed significant hair regrowth while being treated with a higher dose of tocilizumab (TCZ) for posterior uveitis. TCZ is a monoclonal antibody that inhibits interleukin-6 (IL-6), a cytokine implicated in AA. Initially, her AA worsened on TCZ, but after restarting at a higher dose, she achieved almost complete hair regrowth within 4 months. This case suggests a potential role for IL-6 blockade in treating AA, but the exact mechanisms by which TCZ affects hair follicle growth are not fully understood, necessitating further research. The report also notes the possibility that the hair regrowth could have occurred spontaneously and was not necessarily related to IL-6 modulation.
